These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 36992206)

  • 21. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coverage and Equity of Childhood Vaccines in China.
    Zhang H; Lai X; Mak J; Sriudomporn S; Zhang H; Fang H; Patenaude B
    JAMA Netw Open; 2022 Dec; 5(12):e2246005. PubMed ID: 36484985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Strengthening national decision-making on immunization by building capacity for economic evaluation: Implementing ProVac in Europe.
    Blau J; Hoestlandt C; D Clark A; Baxter L; Felix Garcia AG; Mounaud B; Mosina L
    Vaccine; 2015 May; 33 Suppl 1():A34-9. PubMed ID: 25919171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparing Multivariate with Wealth-Based Inequity in Vaccination Coverage in 56 Countries: Toward a Better Measure of Equity in Vaccination Coverage.
    Patenaude BN; Sriudomporn S; Odihi D; Mak J; de Broucker G
    Vaccines (Basel); 2023 Feb; 11(3):. PubMed ID: 36992121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An extended cost-effectiveness analysis of publicly financed HPV vaccination to prevent cervical cancer in China.
    Levin CE; Sharma M; Olson Z; Verguet S; Shi JF; Wang SM; Qiao YL; Jamison DT; Kim JJ
    Vaccine; 2015 Jun; 33(24):2830-41. PubMed ID: 25770785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incorporating Equity Concerns in Cost-Effectiveness Analyses: A Systematic Literature Review.
    Ward T; Mujica-Mota RE; Spencer AE; Medina-Lara A
    Pharmacoeconomics; 2022 Jan; 40(1):45-64. PubMed ID: 34713423
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Equity in disease prevention: Vaccines for the older adults - a national workshop, Australia 2014.
    Raina MacIntyre C; Menzies R; Kpozehouen E; Chapman M; Travaglia J; Woodward M; Jackson Pulver L; Poulos CJ; Gronow D; Adair T
    Vaccine; 2016 Nov; 34(46):5463-5469. PubMed ID: 27686835
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of geographic and economic heterogeneity on the burden of rotavirus diarrhea and the impact and cost-effectiveness of vaccination in Pakistan.
    Rheingans R; Anderson JD; Bagamian KH; Laytner LA; Pecenka CJ; Gilani SSA; Ahmed M
    Vaccine; 2018 Dec; 36(51):7780-7789. PubMed ID: 30007826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. National decision-making for the introduction of new vaccines: A systematic review, 2010-2020.
    Donadel M; Panero MS; Ametewee L; Shefer AM
    Vaccine; 2021 Apr; 39(14):1897-1909. PubMed ID: 33750592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Accounting for Adverse Events Following Immunization in Economic Evaluation: Systematic Review of Economic Evaluations of Pediatric Vaccines Against Pneumococcus, Rotavirus, Human Papillomavirus, Meningococcus and Measles-Mumps-Rubella-Varicella.
    Doggen K; van Hoek AJ; Luyten J
    Pharmacoeconomics; 2023 May; 41(5):481-497. PubMed ID: 36809673
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A guideline for economic evaluations of vaccines and immunization programs in China.
    Fang H; Chen C; Fang Y; He X; Hou Z; Jiang M; Jiang Y; Li S; Liu Y; Sui B; Sun Q; Wu J; Xu T; Yang J; Yin Z; Ying X; Yuan B; Zheng H; Zheng Y
    Hum Vaccin Immunother; 2022 Nov; 18(6):2132802. PubMed ID: 36287462
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Frequency and impact of the inclusion of broader measures of value in economic evaluations of vaccines.
    Silver MC; Neumann PJ; Ma S; Kim DD; Cohen JT; Nyaku M; Roberts C; Sinha A; Ollendorf DA
    Vaccine; 2021 Nov; 39(46):6727-6734. PubMed ID: 34656380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Research on subgroups is not research on equity attributes: Evidence from an overview of systematic reviews on vaccination.
    Bosch-Capblanch X; Zuske MK; Auer C
    Int J Equity Health; 2017 Jun; 16(1):95. PubMed ID: 28592273
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improving the use of research evidence in guideline development: 12. Incorporating considerations of equity.
    Oxman AD; Schünemann HJ; Fretheim A
    Health Res Policy Syst; 2006 Dec; 4():24. PubMed ID: 17147814
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distributional impact of rotavirus vaccination in 25 GAVI countries: estimating disparities in benefits and cost-effectiveness.
    Rheingans R; Atherly D; Anderson J
    Vaccine; 2012 Apr; 30 Suppl 1():A15-23. PubMed ID: 22520124
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness of rotavirus vaccination in Albania.
    Ahmeti A; Preza I; Simaku A; Nelaj E; Clark AD; Felix Garcia AG; Lara C; Hoestlandt C; Blau J; Bino S
    Vaccine; 2015 May; 33 Suppl 1():A201-8. PubMed ID: 25919162
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influenza vaccines in low and middle income countries: a systematic review of economic evaluations.
    Ott JJ; Klein Breteler J; Tam JS; Hutubessy RC; Jit M; de Boer MR
    Hum Vaccin Immunother; 2013 Jul; 9(7):1500-11. PubMed ID: 23732900
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative Distributional Impact of Routine Immunization and Supplementary Immunization Activities in Delivery of Measles Vaccine in Low- and Middle-Income Countries.
    Portnoy A; Jit M; Helleringer S; Verguet S
    Value Health; 2020 Jul; 23(7):891-897. PubMed ID: 32762991
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changing patterns of invasive meningococcal disease and future immunization strategies.
    Taha MK; Bekkat-Berkani R; Abitbol V
    Hum Vaccin Immunother; 2023 Dec; 19(1):2186111. PubMed ID: 37017273
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2003 to 2006.
    Menzies R; Turnour C; Chiu C; McIntyre P
    Commun Dis Intell Q Rep; 2008 Jun; 32 Suppl():S2-67. PubMed ID: 18711998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.